How much revenue did Trevena generate this year?
Trevena has achieved a revenue of 163,200 USD this year.
Trevena Revenue 2024
Trevena Revenue
163,200 USD
Ticker
TRVN
ISIN
US89532E1091
WKN
A1XDSL
In 2024, Trevena's sales reached 163,200 USD, a -94.78% difference from the 3.13 M USD sales recorded in the previous year.
The Trevena Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2028e | 806.95 | 0,18 |
| 2027e | 294.84 | 0,49 |
| 2026e | - | - |
| 2025e | 9.13 | 15,94 |
| 2024e | 0.16 | 891,54 |
| 2023 | 3.13 | 46,56 |
| 2022 | -0.42 | 819,05 |
| 2021 | 0.57 | -68,42 |
| 2020 | 3.07 | 94,14 |
| 2019 | 0.03 | 4850,00 |
| 2018 | 5.73 | 25,39 |
| 2017 | - | - |
| 2016 | 3.75 | 38,80 |
| 2015 | 6.25 | 23,28 |
| 2014 | - | - |
| 2013 | 0.13 | 1119,23 |
| 2012 | 0.81 | 179,63 |
| 2011 | 2.42 | 60,12 |
Trevena Revenue, EBIT, Net Income US89532E1091 · A1XDSL
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Trevena, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Trevena from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Trevena’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Trevena. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Trevena’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Trevena’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Trevena’s growth potential.
Trevena Revenue, EBIT and net profit per share
| Date | Trevena Revenue | Trevena EBIT | Trevena Net Income |
|---|---|---|---|
| 2028e | 806.95 M undefined | 666.1 M undefined | 14.83 M undefined |
| 2027e | 294.84 M undefined | 208.72 M undefined | 5.48 M undefined |
| 2026e | 0 undefined | -34.76 M undefined | -21.46 M undefined |
| 2025e | 9.13 M undefined | -27.12 M undefined | -17.21 M undefined |
| 2024e | 163,200 undefined | -33.41 M undefined | -27.04 M undefined |
| 2023 | 3.13 M undefined | -35.29 M undefined | -40.29 M undefined |
| 2022 | -420,000 undefined | -56.38 M undefined | -53.67 M undefined |
| 2021 | 570,000 undefined | -51.93 M undefined | -51.59 M undefined |
| 2020 | 3.07 M undefined | -29.49 M undefined | -29.37 M undefined |
| 2019 | 30,000 undefined | -26.47 M undefined | -24.87 M undefined |
| 2018 | 5.73 M undefined | -29.07 M undefined | -30.78 M undefined |
| 2017 | 0 undefined | -68.62 M undefined | -71.87 M undefined |
| 2016 | 3.75 M undefined | -102.28 M undefined | -102.99 M undefined |
| 2015 | 6.25 M undefined | -50.62 M undefined | -50.53 M undefined |
| 2014 | 0 undefined | -49.95 M undefined | -49.73 M undefined |
| 2013 | 130,000 undefined | -23.35 M undefined | -23.59 M undefined |
| 2012 | 810,000 undefined | -15.61 M undefined | -15.95 M undefined |
| 2011 | 2.42 M undefined | -15.75 M undefined | -15.88 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2011 | 2.42 M USD | -15.75 M USD | -15.88 M USD |
| 2012 | 810,000 USD | -15.61 M USD | -15.95 M USD |
| 2013 | 130,000 USD | -23.35 M USD | -23.59 M USD |
| 2014 | 0 USD | -49.95 M USD | -49.73 M USD |
| 2015 | 6.25 M USD | -50.62 M USD | -50.53 M USD |
| 2016 | 3.75 M USD | -102.28 M USD | -102.99 M USD |
| 2017 | 0 USD | -68.62 M USD | -71.87 M USD |
| 2018 | 5.73 M USD | -29.07 M USD | -30.78 M USD |
| 2019 | 30,000 USD | -26.47 M USD | -24.87 M USD |
| 2020 | 3.07 M USD | -29.49 M USD | -29.37 M USD |
| 2021 | 570,000 USD | -51.93 M USD | -51.59 M USD |
| 2022 | -420,000 USD | -56.38 M USD | -53.67 M USD |
| 2023 | 3.13 M USD | -35.29 M USD | -40.29 M USD |
| 2024e | 163,200 USD | -33.41 M USD | -27.04 M USD |
| 2025e | 9.13 M USD | -27.12 M USD | -17.21 M USD |
| 2026e | 0 USD | -34.76 M USD | -21.46 M USD |
| 2027e | 294.84 M USD | 208.72 M USD | 5.48 M USD |
| 2028e | 806.95 M USD | 666.1 M USD | 14.83 M USD |
Trevena stock margins US89532E1091 · A1XDSL
The Trevena margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Trevena. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Trevena.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Trevena's sales revenue. A higher gross margin percentage indicates that the Trevena retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Trevena's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Trevena's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Trevena's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Trevena. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Trevena's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Trevena Margin History
| Trevena Gross margin | Trevena Profit margin | Trevena EBIT margin | Trevena Profit margin |
|---|---|---|---|
| 2028e | 46.56 % | 82.55 % | 1.84 % |
| 2027e | 46.56 % | 70.79 % | 1.86 % |
| 2026e | 46.56 % | 0 % | 0 % |
| 2025e | 46.56 % | -297.07 % | -188.52 % |
| 2024e | 46.56 % | -20,470.63 % | -16,568.36 % |
| 2023 | 46.56 % | -1,129.22 % | -1,289.25 % |
| 2022 | 819.05 % | 13,423.81 % | 12,778.57 % |
| 2021 | -68.42 % | -9,110.53 % | -9,050.88 % |
| 2020 | 94.14 % | -960.59 % | -956.68 % |
| 2019 | 46.56 % | -88,233.33 % | -82,900.01 % |
| 2018 | 46.56 % | -507.33 % | -537.17 % |
| 2017 | 46.56 % | 0 % | 0 % |
| 2016 | 46.56 % | -2,727.47 % | -2,746.4 % |
| 2015 | 46.56 % | -809.92 % | -808.48 % |
| 2014 | 46.56 % | 0 % | 0 % |
| 2013 | 46.56 % | -17,961.54 % | -18,146.16 % |
| 2012 | 46.56 % | -1,927.16 % | -1,969.14 % |
| 2011 | 46.56 % | -650.83 % | -656.2 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2011 | 46.56 % | -650.83 % | -656.2 % |
| 2012 | 46.56 % | -1,927.16 % | -1,969.14 % |
| 2013 | 46.56 % | -17,961.54 % | -18,146.16 % |
| 2014 | 46.56 % | 0 % | 0 % |
| 2015 | 46.56 % | -809.92 % | -808.48 % |
| 2016 | 46.56 % | -2,727.47 % | -2,746.4 % |
| 2017 | 46.56 % | 0 % | 0 % |
| 2018 | 46.56 % | -507.33 % | -537.17 % |
| 2019 | 46.56 % | -88,233.33 % | -82,900.01 % |
| 2020 | 94.14 % | -960.59 % | -956.68 % |
| 2021 | -68.42 % | -9,110.53 % | -9,050.88 % |
| 2022 | 819.05 % | 13,423.81 % | 12,778.57 % |
| 2023 | 46.56 % | -1,129.22 % | -1,289.25 % |
| 2024e | 46.56 % | -20,470.63 % | -16,568.36 % |
| 2025e | 46.56 % | -297.07 % | -188.52 % |
| 2026e | 46.56 % | 0 % | 0 % |
| 2027e | 46.56 % | 70.79 % | 1.86 % |
| 2028e | 46.56 % | 82.55 % | 1.84 % |
Trevena Aktienanalyse
What does Trevena do?
Trevena Inc is an international company specializing in drug development. It was founded in 2007 and is headquartered in Pennsylvania, USA. The history of Trevena begins with the discovery of G-protein coupled receptors (GPCRs), a group of proteins responsible for various biological processes in the body. The founders of Trevena recognized that blocking these receptors could contribute to pain relief and other diseases. With this knowledge, Trevena embarked on comprehensive research and development to develop new drugs. Trevena's business model is based on the development of drugs based on GPCR blockers. The company aims to specifically target diseases for which there is currently no satisfactory therapy. In close collaboration with leading scientists and doctors worldwide, Trevena's researchers and developers are working on the development of innovative drugs for a wide range of diseases. Trevena is divided into different divisions that focus on the development of drugs for different disease areas. These include pain therapy, cardiovascular diseases, and respiratory diseases. One of Trevena's most well-known products is their pain therapeutic Olinvyk (Oliceridine), which is approved for use in patients with moderate to severe pain. The drug is a GPCR blocker that works faster than other painkillers and has minimal side effects. Olinvyk is used in postoperative pain therapy and has the potential to reduce the use of opioids. Another promising drug from Trevena is TRV027, which was developed to treat cardiovascular diseases. The drug aims to reduce the effects of heart attacks and other cardiovascular events and has shown promising results in clinical studies. Trevena is constantly striving to intensify its research and development efforts and expand its product range. The company works closely with regulatory authorities worldwide to ensure the safety and efficacy of its drugs and achieve fast market approval. Overall, the company has made significant progress in recent years and has already brought several drugs to market that have the potential to significantly improve healthcare. The future of Trevena looks promising and holds hope for further innovative drugs. Trevena ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Trevena's Sales Figures
The sales figures of Trevena originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Trevena’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Trevena's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Trevena’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Trevena stock
How much was the turnover of the company Trevena compared to the previous year?
The revenue of Trevena has increased by -94.78% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Trevena?
The revenue of Trevena is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Trevena measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Trevena so important for investors?
The revenue of Trevena is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Trevena pay?
Over the past 12 months, Trevena paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Trevena is expected to pay a dividend of 0 USD.
What is the dividend yield of Trevena?
The current dividend yield of Trevena is .
When does Trevena pay dividends?
Trevena pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Trevena?
Trevena paid dividends every year for the past 0 years.
What is the dividend of Trevena?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Trevena located?
Trevena is assigned to the 'Health' sector.
Wann musste ich die Aktien von Trevena kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Trevena from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.
When did Trevena pay the last dividend?
The last dividend was paid out on 11/17/2024.
What was the dividend of Trevena in the year 2023?
In the year 2023, Trevena distributed 0 USD as dividends.
In which currency does Trevena pay out the dividend?
The dividends of Trevena are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Trevena
Our stock analysis for Trevena Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Trevena Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
